Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP)

[1]  M. Nikiforova,et al.  Characterization of activating mutations of the MEK1 gene in papillary thyroid carcinomas. , 2019, Thyroid : official journal of the American Thyroid Association.

[2]  J. Hennessey,et al.  Systematic Review and Meta-analysis of the Impact of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Cytological Diagnosis and Thyroid Cancer Prevalence , 2019, Endocrine Pathology.

[3]  M. Bongiovanni,et al.  The impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) on the diagnosis of thyroid nodules. , 2019, Gland surgery.

[4]  G. Tomlinson,et al.  The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms. , 2019, JAMA oncology.

[5]  P. Prah,et al.  Early surveillance is associated with less incidence and severity of breast cancer–related lymphedema compared with a traditional referral model of care , 2018, Cancer.

[6]  Y. Hung,et al.  A user's guide to non‐invasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP) , 2018, Histopathology.

[7]  R. Seethala,et al.  Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists , 2018, Modern Pathology.

[8]  Jeffrey K. Mito,et al.  A modified reporting approach for thyroid FNA in the NIFTP era: A 1‐year institutional experience , 2017, Cancer cytopathology.

[9]  P. Rosário.  Ultrasonography and cytology as predictors of noninvasive follicular thyroid (NIFTP) neoplasm with papillary‐like nuclear features: importance of the differential diagnosis with the invasive encapsulated follicular variant of papillary thyroid cancer , 2017, Clinical endocrinology.

[10]  M. Hirokawa,et al.  Low Rate of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice. , 2017, Thyroid : official journal of the American Thyroid Association.

[11]  T. Scognamiglio,et al.  Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma , 2017, Diagnostic cytopathology.

[12]  A. Simsir,et al.  Can noninvasive follicular thyroid neoplasm with papillary‐like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine‐needle aspiration? , 2017, Cancer cytopathology.

[13]  A. Renshaw,et al.  Incidence and significance of true papillae in thyroid fine needle aspiration* , 2017, Diagnostic cytopathology.

[14]  XuBin,et al.  Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics. , 2017 .

[15]  D. Dias-Santagata,et al.  Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary‐like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma , 2017, Cancer cytopathology.

[16]  T. Corte,et al.  Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF) , 2017, Journal of clinical medicine.

[17]  F. KraneJeffrey,et al.  Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of “Carcinomas” Harboring RAS Mutations , 2017 .

[18]  R. Paschke,et al.  Molecular profiling of thyroid nodule fine-needle aspiration cytology , 2017, Nature Reviews Endocrinology.

[19]  B. Ljung,et al.  Cytomorphologic Features of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): A Comparison with Infiltrative Follicular Variant of Papillary Thyroid Carcinoma , 2017 .

[20]  Bin Xu,et al.  Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics. , 2017, Thyroid : official journal of the American Thyroid Association.

[21]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[22]  Marian Harris,et al.  Institutional implementation of clinical tumor profiling on an unselected cancer population. , 2016, JCI insight.

[23]  E. Alexander,et al.  Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis. , 2016, Thyroid : official journal of the American Thyroid Association.

[24]  L. Larocca,et al.  Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary‐like nuclear features on liquid‐based cytology: Some insights into their identification , 2016, Cancer cytopathology.

[25]  A. Tischler,et al.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. , 2016, JAMA oncology.

[26]  M. Papotti,et al.  Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology. , 2016, Human pathology.

[27]  G. Kilicoglu,et al.  New Concept of the Encapsulated Follicular Variant of Papillary Thyroid Carcinoma and Its Impact on the Bethesda System for Reporting Thyroid Cytopathology: A Single-Institute Experience , 2016, Acta Cytologica.

[28]  M. Nikiforova,et al.  NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States , 2016, Cancer.

[29]  C. Longui,et al.  AGK‐BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma , 2016, Cancer medicine.

[30]  J. Hennessey,et al.  A 2015 Survey of Clinical Practice Patterns in the Management of Thyroid Nodules. , 2016, The Journal of clinical endocrinology and metabolism.

[31]  J. Bishop,et al.  Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology , 2016, Cancer cytopathology.

[32]  AfkhamiMichelle,et al.  Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAFK601E Mutation , 2016 .

[33]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[34]  Simion I. Chiosea,et al.  Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation. , 2016, Thyroid : official journal of the American Thyroid Association.

[35]  R. Paschke,et al.  Fine-needle aspiration diagnoses of noninvasive follicular variant of papillary thyroid carcinoma. , 2015, American journal of clinical pathology.

[36]  J. Barletta,et al.  Absence of BRAF V600E in non‐infiltrative, non‐invasive follicular variant of papillary thyroid carcinoma , 2015, Histopathology.

[37]  Ling Lin,et al.  MAP2K1 and MAP3K1 mutations in langerhans cell histiocytosis , 2015, Genes, chromosomes & cancer.

[38]  D. Muzny,et al.  Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. , 2014, Blood.

[39]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.

[40]  Larissa V Furtado,et al.  High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. , 2014, Blood.

[41]  J. Bishop,et al.  BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  L. Sholl,et al.  Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma. , 2013, Thyroid : official journal of the American Thyroid Association.

[43]  J. Bishop,et al.  Highly prevalent TERT promoter mutations in aggressive thyroid cancers. , 2013, Endocrine-related cancer.

[44]  R. Paschke,et al.  Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. , 2012, Thyroid : official journal of the American Thyroid Association.

[45]  C. V. Jongeneel,et al.  Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma , 2011, Nature Genetics.

[46]  J. Ricarte-Filho,et al.  Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns , 2010, Modern Pathology.

[47]  E. Cibas,et al.  The Bethesda system for reporting thyroid cytopathology : definitions, criteria, and explanatory notes , 2010 .